DK611689A - Stereospecifik fremgangsmaade til fremstilling af enantiomere af 3-substituerede furo(3,4-c)pyridiner, saadanne enentiomere og terapeutiske praeparater indeholdende disse - Google Patents

Stereospecifik fremgangsmaade til fremstilling af enantiomere af 3-substituerede furo(3,4-c)pyridiner, saadanne enentiomere og terapeutiske praeparater indeholdende disse Download PDF

Info

Publication number
DK611689A
DK611689A DK611689A DK611689A DK611689A DK 611689 A DK611689 A DK 611689A DK 611689 A DK611689 A DK 611689A DK 611689 A DK611689 A DK 611689A DK 611689 A DK611689 A DK 611689A
Authority
DK
Denmark
Prior art keywords
enentiomers
stereospecific
pyridines
procedure
preparations containing
Prior art date
Application number
DK611689A
Other languages
English (en)
Other versions
DK167020B1 (da
DK611689D0 (da
Inventor
Marc Bonato
Charles Eck
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of DK611689A publication Critical patent/DK611689A/da
Publication of DK611689D0 publication Critical patent/DK611689D0/da
Application granted granted Critical
Publication of DK167020B1 publication Critical patent/DK167020B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
DK611689A 1988-04-06 1989-12-05 Stereospecifik fremgangsmaade til fremstilling af enantiomere af 3-substituerede furo(3,4-c)pyridiner DK167020B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888808001A GB8808001D0 (en) 1988-04-06 1988-04-06 Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8808001 1988-04-06
FR8900157 1989-01-09
PCT/FR1989/000157 WO1989009772A1 (fr) 1988-04-06 1989-04-06 PROCEDE STEREOSPECIFIQUE POUR LA PREPARATION DES ENANTIOMERES DE LA FURO[3,4-c]PYRIDINE, COMPOSES AINSI OBTENUS ET COMPOSITIONS THERAPEUTIQUES A BASE DE CES COMPOSES

Publications (3)

Publication Number Publication Date
DK611689A true DK611689A (da) 1989-12-05
DK611689D0 DK611689D0 (da) 1989-12-05
DK167020B1 DK167020B1 (da) 1993-08-16

Family

ID=10634633

Family Applications (1)

Application Number Title Priority Date Filing Date
DK611689A DK167020B1 (da) 1988-04-06 1989-12-05 Stereospecifik fremgangsmaade til fremstilling af enantiomere af 3-substituerede furo(3,4-c)pyridiner

Country Status (28)

Country Link
US (1) US5026855A (da)
EP (1) EP0337858B1 (da)
JP (1) JP2680456B2 (da)
KR (1) KR970005308B1 (da)
AT (1) AT397093B (da)
AU (1) AU616753B2 (da)
BE (1) BE1003843A4 (da)
CA (1) CA1338475C (da)
CH (1) CH680000A5 (da)
DK (1) DK167020B1 (da)
DZ (1) DZ1335A1 (da)
ES (1) ES2057159T3 (da)
FI (1) FI93116C (da)
FR (2) FR2629821B1 (da)
GB (2) GB8808001D0 (da)
IE (1) IE61915B1 (da)
IN (1) IN172987B (da)
MA (1) MA21529A1 (da)
MY (1) MY104424A (da)
NL (1) NL8920307A (da)
NZ (1) NZ228614A (da)
OA (1) OA09247A (da)
PT (1) PT90210B (da)
SE (1) SE509130C2 (da)
SG (1) SG40492G (da)
TN (1) TNSN89043A1 (da)
WO (1) WO1989009772A1 (da)
ZA (1) ZA892477B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
GB2423927A (en) * 2003-08-29 2006-09-13 Cotherix Inc Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
JP2010514841A (ja) * 2007-01-03 2010-05-06 グレン ブイ． コルネット， 肺疾患および心疾患の処置におけるシクレタニンおよびｐｋｃ阻害剤
AR073259A1 (es) * 2008-07-29 2010-10-28 Merck & Co Inc Derivados de furosemida utiles como diureticos
US8377911B2 (en) 2009-10-09 2013-02-19 Merck Sharp & Dohme Corp. Diuretics
WO2015103445A1 (en) * 2013-12-31 2015-07-09 Rockey Don C Systems, methods, techniques, and compounds in research and treatment of portal hypertension and other conditions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IN156817B (da) * 1981-02-10 1985-11-09 Scras
IN160104B (da) * 1983-04-05 1987-06-27 Scras
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
ZA842029B (en) * 1983-04-05 1984-10-31 Scras Furo-(3,4-c)-pyridine derivatives preparation thereof and therapeutic compositions containing the same
GB2137618B (en) * 1983-04-05 1986-05-08 Scras Furo-(3,4-c)-pyridine derivatives
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8422029D0 (en) * 1984-08-31 1984-10-03 Scras 6-substituted-furo-(3 4-c)-pyridine derivatives
GB8422379D0 (en) * 1984-09-05 1984-10-10 Scras Derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
PT90210A (pt) 1989-11-10
AT397093B (de) 1994-01-25
AU3419089A (en) 1989-11-03
JPH02504394A (ja) 1990-12-13
FR2629820A1 (fr) 1989-10-13
FI93116B (fi) 1994-11-15
SG40492G (en) 1992-06-12
SE8904104L (sv) 1989-12-05
FI93116C (fi) 1995-02-27
IN172987B (da) 1994-01-15
FR2629821B1 (fr) 1993-12-03
GB2235194B (en) 1992-01-29
DK167020B1 (da) 1993-08-16
FR2629821A1 (fr) 1989-10-13
BE1003843A4 (fr) 1992-06-30
FI895826A0 (fi) 1989-12-05
ES2057159T3 (es) 1994-10-16
DK611689D0 (da) 1989-12-05
KR970005308B1 (ko) 1997-04-15
NL8920307A (nl) 1990-03-01
CA1338475C (en) 1996-07-23
TNSN89043A1 (fr) 1991-02-04
WO1989009772A1 (fr) 1989-10-19
SE509130C2 (sv) 1998-12-07
EP0337858B1 (fr) 1994-06-08
FR2629820B1 (fr) 1993-12-03
US5026855A (en) 1991-06-25
ATA900589A (de) 1993-06-15
KR900700483A (ko) 1990-08-13
SE8904104D0 (sv) 1989-12-05
EP0337858A1 (fr) 1989-10-18
IE891076L (en) 1989-10-06
MY104424A (en) 1994-03-31
GB8927509D0 (en) 1990-06-13
DZ1335A1 (fr) 2004-09-13
AU616753B2 (en) 1991-11-07
GB2235194A (en) 1991-02-27
IE61915B1 (en) 1994-11-30
MA21529A1 (fr) 1989-12-31
PT90210B (pt) 1994-06-30
CH680000A5 (da) 1992-05-29
JP2680456B2 (ja) 1997-11-19
NZ228614A (en) 1990-11-27
OA09247A (fr) 1992-06-30
ZA892477B (en) 1989-12-27
GB8808001D0 (en) 1988-05-05

Similar Documents

Publication Publication Date Title
DK662887D0 (da) Fladeformigt terapeutisk system, fremgangsmaade til fremstilling deraf og anvendelse deraf
DK664887A (da) 3-substituerede 3-aroyloxy-propanaminer og fremgangsmaade til fremstilling deraf
DK86688A (da) Maettede heterocycliske carboxamidderivater og fremgangsmaade til fremstilling heraf
DK542584D0 (da) 1,3-dihydro-6-vinyl-7-hydroxy-furo-(3,4-c)pyridin-derivater, fremgangsmaade til fremstilling af disse samt farmaceutisk praeparat indeholdende disse
DK611689D0 (da) Stereospecifik fremgangsmaade til fremstilling af enantiomere af 3-substituerede furo(3,4-c)pyridiner, saadanne enentiomere og terapeutiske praeparater indeholdende disse
DK45585D0 (da) 6-substituerede furo-(3,4-c)-pyridin-derivater, fremgangsmaade til fremstilling af disse samt terapeutisk middel indeholdende disse
DK545684D0 (da) 1,3-dihydro-6-methyl-furo-(3,4-c)-pyridin-derivater, fremgangsmaade til fremstilling af disse samt farmaceutisk praeparat indeholdende disse
DK178084D0 (da) 1,3-dihydro-6-methyl-7-hydrosyfuro-(3,4-c)-pyridinderivater og fremgangsmade til fremstilling deraf
DK502389D0 (da) Pyridazinonderivater og fremgangsmaade til fremstilling deraf
DK435588A (da) Aralkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende disse
DK343088D0 (da) Pyrazinderivater, fremgangsmaade til fremstilling heraf, midler indeholdende disse og fremgangsmaader til regulering af plantevaekst
DK304090A (da) Glycerolderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK315486D0 (da) 4,7-dihydrothieno(2,3-b)pyridinderivater, fremgangsmaade til fremstilling deraf samt praeparater indeholdende disse praeparater
DK396385A (da) 2,3-dihydro-lh-indenderivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser
DK293786D0 (da) Steroido(3,2-c)pyrazol og fremgangsmaade til fremstilling deraf
DK67786D0 (da) Fremgangsmaade til fremstilling af arylglycidylethere og 3-substituerede 1-alkylamino-2-propanoler
DK93385A (da) 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoliner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
DK299590A (da) Phospholipidderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK237287D0 (da) Propargyloxybenzen-derivater, fremgangsmaade til fremstilling deraf og praeparater med fungicid virkning indeholdende disse derivater
DK245787A (da) Nicotinsyrederivater, fremgangsmaade til fremstilling deraf og praeparater med fungicid virkning indeholdende disse derivater
DK276888D0 (da) 3-acylaminomethyl-5,6,7,8-tetrahydro-imidazooe,2-a aapyridinderivater, fremgangsmaade til fremstilling af og laegemiddel indeholdende saadanne derivater
DK159779C (da) Substituerede phenoxypropylthiopyrazolo(1,5-a)-pyridin- eller -benzimidazolderivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende disse forbindelser
DK343988A (da) Praeparater med kontrolleret afgivelseshastighed af nulte orden, og fremgangsmaade til fremstilling af saasanne praeparater
DK276690A (da) Selenophenderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK402885D0 (da) 1,3-dihydro-6-aminomethyl-7-hydroxy-furo-(3,4-c)-pyridin-derivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne forbindelser

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK